azathioprine has been researched along with Metal Metabolism, Inborn Errors in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Metal Metabolism, Inborn Errors: Dysfunctions in the metabolism of metals resulting from inborn genetic mutations that are inherited or acquired in utero.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Powell, LW | 1 |
| Tolman, KG | 1 |
1 review available for azathioprine and Metal Metabolism, Inborn Errors
| Article | Year |
|---|---|
Treatment of inflammatory and metal storage diseases of the liver.
Topics: Adrenal Cortex Hormones; Azathioprine; Bloodletting; Chelating Agents; Chronic Disease; Copper; Fema | 1979 |